| __timestamp | Insmed Incorporated | Novo Nordisk A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 31073000 | 26760000000 |
| Thursday, January 1, 2015 | 43216000 | 32169000000 |
| Friday, January 1, 2016 | 50679000 | 32339000000 |
| Sunday, January 1, 2017 | 79171000 | 32124000000 |
| Monday, January 1, 2018 | 168218000 | 33313000000 |
| Tuesday, January 1, 2019 | 210796000 | 35830000000 |
| Wednesday, January 1, 2020 | 203613000 | 36886000000 |
| Friday, January 1, 2021 | 234273000 | 41058000000 |
| Saturday, January 1, 2022 | 265784000 | 50684000000 |
| Sunday, January 1, 2023 | 344501000 | 61598000000 |
| Monday, January 1, 2024 | 67377000000 |
Data in motion
In the world of pharmaceuticals, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key indicator of a company's growth trajectory. Over the past decade, Novo Nordisk A/S and Insmed Incorporated have showcased contrasting patterns in their SG&A expenditures. From 2014 to 2023, Novo Nordisk's SG&A expenses have surged by approximately 130%, reflecting its aggressive market expansion and robust R&D investments. In contrast, Insmed's SG&A spending has increased by over 1,000%, highlighting its rapid scaling efforts and market penetration strategies. By 2023, Novo Nordisk's SG&A expenses were nearly 180 times greater than Insmed's, underscoring its dominant market position. This comparison not only illustrates the diverse strategies of these pharmaceutical giants but also offers insights into their future market dynamics.
Eli Lilly and Company or Insmed Incorporated: Who Manages SG&A Costs Better?
Novo Nordisk A/S vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Novo Nordisk A/S vs Xenon Pharmaceuticals Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and Protagonist Therapeutics, Inc.
Novo Nordisk A/S vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Dynavax Technologies Corporation
Novo Nordisk A/S or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Johnson & Johnson vs Insmed Incorporated
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Insmed Incorporated
Insmed Incorporated and Madrigal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Insmed Incorporated or Verona Pharma plc: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Insmed Incorporated or Travere Therapeutics, Inc.